$NIO $TWNK $EVFM People should be buying these list of stocks. Nio is self explanatory. Hostess is averaging over 20% year over year retained earnings for stockholders and same with equity. Evofem having the only FDA approved female birth control that isn't hormonal is huge. Plus the fact they are starting phase 3 trial on a non antibiotic treatment for Chlamydia and Gonorrhea in women. If that gets approved it will basically give them a monopoly on STD treatment.
  • 3
3 Likes